Bioavailability and Safety of Dihydroquercetin (Review)
- PMID: 35194263
- PMCID: PMC8831168
- DOI: 10.1007/s11094-022-02548-8
Bioavailability and Safety of Dihydroquercetin (Review)
Abstract
Dihydroquercetin (DHQ) is a bioflavonoid with high antioxidant, capillary-protective, and anti-inflammatory activity. DHQ has previously been used for treating Middle East respiratory syndrome coronavirus (MERS-CoV) infection and is currently considered a potential regulator of oxidative stress as part of COVID-19 multipurpose therapy. DHQ has a high safety profile but low bioavailability that limits its use. Innovative techniques (liposomization, crystal engineering, etc.) can be used to increase its bioavailability.
Keywords: SARS-CoV-2; bioavailability; dihydroquercetin; safety; toxicity.
© Springer Science+Business Media, LLC, part of Springer Nature 2022.
References
-
- V. A. Babkin, Larch Biomass: From Chemical Composition to Innovative Products [in Russian], Izd. Sib. Otd. Ross. Akad. Nauk, Novosibirsk (2011), p. 236.
-
- Efficacy and Safety Study of Diquertin Preparation: Final Report [in Russian], NPO VILAR (1999).
-
- B. Havsteen, Biochem. Pharmacol., No. 2, 1141 – 1148 (1983). - PubMed
-
- Rice-Evans C, Miller N, Paganga G. Trends Plant Sci. 1997;2:152–159. doi: 10.1016/S1360-1385(97)01018-2. - DOI
-
- N. V. Kondakova, S. I. Zaichkina, O. M. Rozanova, et al., Vopr. Biol., Med. Farm. Khim., No. 4, 46 – 49 (2002).
LinkOut - more resources
Full Text Sources
Miscellaneous